Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TATA Health International Holdings Ltd. ( (HK:1255) ) just unveiled an update.
TATA Health International Holdings Ltd. has provided supplemental details on its previously announced disposal of a target company, clarifying the treatment of certain security interests tied to a HK$20 million credit facility. The facility had been secured by a legal charge over properties held by KTS HK, as well as floating charges over inventories of Grand Asian Ltd. and receivables of KTS HK.
Following completion of the disposal on 13 March 2026, the floating charge over the inventories of Grand Asian Ltd., an indirect wholly owned subsidiary of the group, has been released. In addition, KTS HK has become an indirect wholly owned subsidiary of the purchaser and lender, meaning the remaining charges over its properties and receivables no longer affect TATA Health’s group, reducing the group’s encumbrances and credit exposure tied to the disposed assets.
More about TATA Health International Holdings Ltd.
TATA Health International Holdings Ltd. is a Hong Kong-listed company incorporated in the Cayman Islands, operating through various subsidiaries in its group structure. The company is overseen by a board comprising an executive director, non-executive directors, and independent non-executive directors, reflecting a typical governance framework for a listed holding company.
Average Trading Volume: 126,963
Technical Sentiment Signal: Buy
Current Market Cap: HK$347.3M
For a thorough assessment of 1255 stock, go to TipRanks’ Stock Analysis page.